Wave Life Sciences (WVE) EBIT (2014 - 2026)
Wave Life Sciences posted quarterly EBIT of -$31.3 million for Q1 2026, up 37.16% year-on-year from -$22.8 million in Q1 2025, and up 44.57% on a QoQ basis from -$56.5 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of EBIT data on file, last reported at -$31.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 37.16% year-over-year to -$31.3 million; the trailing twelve-month figure through Mar 2026 stood at -$196.9 million (down 56.56% YoY), and the FY2025 full-year result was -$215.4 million, down 95.09% from the prior year.
- EBIT for Q1 2026 stood at -$31.3 million, up from -$56.5 million in the prior quarter.
- Across five years, EBIT topped out at $23.0 million in Q4 2024 and bottomed at -$63.9 million in Q3 2024.
- The 5-year median for EBIT is -$38.1 million (2022), against an average of -$34.6 million.
- Peak annual rise in EBIT reached 222.94% in 2024, while the deepest fall reached 1538.23% in 2024.
- A 5-year view of EBIT shows it stood at -$43.6 million in 2022, then surged by 57.11% to -$18.7 million in 2023, then surged by 222.94% to $23.0 million in 2024, then sank by 345.86% to -$56.5 million in 2025, then jumped by 44.57% to -$31.3 million in 2026.
- The last three EBIT figures came in at -$31.3 million (Q1 2026), -$56.5 million (Q4 2025), and -$56.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -31.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.30 Mn |
| Dec 31, 2025 | -56.47 Mn |
| Sep 30, 2025 | -56.35 Mn |
| Jun 30, 2025 | -52.76 Mn |
| Mar 31, 2025 | -49.80 Mn |
| Dec 31, 2024 | 22.97 Mn |
| Sep 30, 2024 | -63.92 Mn |
| Jun 30, 2024 | -35.00 Mn |
| Mar 31, 2024 | -34.46 Mn |
| Dec 31, 2023 | -18.68 Mn |
| Sep 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | -23.47 Mn |
| Mar 31, 2023 | -30.29 Mn |
| Dec 31, 2022 | -43.56 Mn |
| Sep 30, 2022 | -38.90 Mn |
| Jun 30, 2022 | -42.16 Mn |
| Mar 31, 2022 | -38.09 Mn |
| Dec 31, 2021 | -36.11 Mn |
| Sep 30, 2021 | -7.61 Mn |
| Jun 30, 2021 | -39.83 Mn |
| Mar 31, 2021 | -43.47 Mn |
| Dec 31, 2020 | -30.31 Mn |
| Sep 30, 2020 | -34.42 Mn |
| Jun 30, 2020 | -38.66 Mn |
| Mar 31, 2020 | -49.99 Mn |
| Dec 31, 2019 | -60.53 Mn |
| Sep 30, 2019 | -54.18 Mn |
| Jun 30, 2019 | -45.62 Mn |
| Mar 31, 2019 | -47.99 Mn |
| Dec 31, 2018 | -48.94 Mn |
| Sep 30, 2018 | -38.23 Mn |
| Jun 30, 2018 | -36.57 Mn |
| Mar 31, 2018 | -35.78 Mn |
| Dec 31, 2017 | -31.16 Mn |
| Sep 30, 2017 | -26.35 Mn |
| Jun 30, 2017 | -24.67 Mn |
| Mar 31, 2017 | -20.21 Mn |
| Dec 31, 2016 | -18.50 Mn |
| Sep 30, 2016 | -17.23 Mn |
| Jun 30, 2016 | -11.64 Mn |
| Mar 31, 2016 | -7.95 Mn |
| Dec 31, 2015 | -7.21 Mn |
| Sep 30, 2015 | -4.99 Mn |
| Jun 30, 2015 | -3.63 Mn |
| Mar 31, 2015 | -3.47 Mn |
| Dec 31, 2014 | -1.78 Mn |
| Sep 30, 2014 | -1.35 Mn |